Cargando…

Impact of Platelet Reactivity in ACS Patients on Clinical Outcomes with Triple Antithrombotic Therapy

Optimal antithrombotic therapy after percutaneous coronary intervention (PCI) in patients on oral anticoagulants (OAC) remains a clinical conundrum. In fact, combining an OAC with dual antiplatelet therapy (triple antithrombotic therapy, TAT) increases the risk of bleeding. Clopidogrel is the only t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gruttemeier, Julia, Cottin, Yves, Yao, Hermann, De Maistre, Emmanuel, Maza, Maud, Bonello, Laurent, Laine, Marc, Resseguier, Noemie, Zeller, Marianne, Camoin-Jau, Laurence, Paganelli, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068113/
https://www.ncbi.nlm.nih.gov/pubmed/33917717
http://dx.doi.org/10.3390/jcm10081565

Ejemplares similares